NATR

Business Context and Reporting Period

Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2005
Business Overview: The Company manufactures and distributes health and wellness products through a direct sales model involving independent Distributors and Managers. Operations are divided into three segments: Nature's Sunshine Products (United States and International) and Synergy Worldwide.

Key Financial Metrics

Note: All financial figures are in thousands unless otherwise noted. Working capital calculated as Current Assets ($99.9M) minus Current Liabilities ($53.1M).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 11.2% year-over-year, driven by volume growth across all segments. Synergy Worldwide saw the most significant growth (31.5% increase), while International sales rose 12.1% and U.S. sales rose 2.2%.
• Profitability: Operating income increased 54.0% to $5.6 million. Net income rose 32.8% to $4.0 million. The effective tax rate decreased to 29.5% from 33.0% in the prior year.
• Expense Trends: Cost of goods sold (COGS) as a percentage of sales improved to 17.0% from 19.8%, attributed to manufacturing efficiencies and a higher mix of Synergy sales. Volume incentives increased to 38.8% of sales (from 38.0%) due to the Synergy mix. SG&A expenses rose 11.9% primarily due to expansion costs in Japan.
• Cash Flow: Operating cash flow decreased significantly to $1.7 million from $9.0 million in the prior year, largely due to changes in accrued liabilities and income taxes payable.
• Other Income: Other income dropped 91.2% to $74,000, primarily due to foreign exchange losses.

Guidance, Outlook, and Risks

• Outlook: Management expects COGS as a percentage of sales to increase slightly for the remainder of 2005. Volume incentives are expected to remain relatively constant as a percentage of sales. SG&A as a percentage of sales is expected to decrease due to cost controls and continued revenue growth. The effective tax rate is expected to increase slightly for the balance of the year.
• Operational Changes: Synergy Worldwide completed a transition to an "on-the-ground" distribution method in Japan during Q1 2005, which temporarily reduced distributor counts but is expected to support long-term growth.
• Product Liability Risk: The Company self-insures for product liabilities. Due to regulatory scrutiny on ingredients like ephedra and kava, the Company cannot obtain external insurance for these specific products. While a captive insurance company was established in 2003, there is no assurance that accrued liabilities will be sufficient to cover future claims.
• Market Risk: Approximately 56.5% of revenue is generated outside the U.S. The Company is exposed to foreign currency fluctuations but does not use derivative instruments for hedging. A strengthening U.S. dollar negatively impacts operating results.
• Liquidity: The Company has a $15 million unsecured line of credit with $10 million outstanding. Management intends to pay off this line during 2005.

Investor Verification Checklist

• Accrued Liabilities: Verify the adequacy of the $16.3 million accrued volume incentives and the $16.3 million in other accrued liabilities, noting the significant decrease in accrued liabilities due to bonus payments.
• Self-Insurance Reserves: Review the actuarial assumptions used for self-insured product liability and employee medical claims, given the inability to insure specific ingredients.
• Foreign Exchange Exposure: Assess the impact of currency fluctuations on the 56.5% of revenue generated internationally, particularly in markets like Russia, Japan, and the Dominican Republic (which became highly inflationary).
• Segment Performance: Monitor the stabilization of the Synergy Worldwide segment following the distribution method change in Japan.
• Debt Covenants: Confirm continued compliance with the affirmative and negative financial covenants on the $10 million line of credit.